Daclizumab Antibody
Daclizumab (Zenapax) is a humanized monoclonal antibody targeting the CD25 alpha subunit of the IL-2 receptor, thereby blocking IL-2 binding. It has been investigated in research contexts, including in vitro assays and clinical studies for autoimmune conditions like multiple sclerosis, to modulate T-cell mediated immune responses.
Product Specifications
Product Name Alternative
Zenapax, Ro 24-7375, Daclizumab, ILReceptor, IL-2, IL Receptor
Target
Interleukin, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
19.92 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.12 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC141026-500 1x 500 µL
CD70 (TNFS7/1026), CF514 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
